does glp 1 lower glucose levels GLP-1 targets multiple organs to improve control in T2DM. GLP-1... DID YOU KNOW? GLP-1 medications

Learn why these GLP-1s underperform and how SLM+ helps you break through plateaus and keep losing weight.

GLP-1 receptor agonists are not recommended during pregnancy due to limited human safety data and animal study findings

Indias pharma industry is strong

Synthetic dyes

Based on this review, evidence from head-to-head and insulin-comparator trials demonstrates that dual GIP/GLP-1 co-agonism consistently overcomes metabolic plateaus that result from single-pathway therapy, producing superior glycated hemoglobin reduction, bariatric-level weight loss (up to 25.3%), and robust macrovascular and heart failure protection, including a 38% reduction in composite cardiovascular risk among patients with heart failure with preserved ejection fraction (HFpEF)

Backed by strong clinical evidence, GLP-1s are winning over doctors and patients alike and are reshaping treatment paradigms across comorbid conditions